Clinical trial

An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604

NCT06157255

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention AZD4604 Inhalation Powder, 1 mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [14C]AZD4604 Solution for Infusion 6 μg/mL (NMT 37.0 kBq/5 mL) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [14C]AZD4604 Oral Solution, 4 mg (NMT 37.0 kBq) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-02-16

PhasePHASE1

Conditions

Asthmaverified · MONDO: asthma

Interventions

AZD4604 Inhalation Powder, 1 mgDRUG

[14C]AZD4604 Solution for Infusion 6 μg/mL (NMT 37.0 kBq/5 mL)DRUG

[14C]AZD4604 Oral Solution, 4 mg (NMT 37.0 kBq)DRUG

Sponsors & collaborators

AstraZenecalead sponsor

Quotient Sciencescollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06157255 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.